GLOBAL HEALTH & SOCIAL MEDICINE
Dr. Keshavjee’s research spans four areas: (1) multi-drug resistant tuberculosis (MDR-TB) treatment and policy; (2) health-sector reform and access to health care and medical technology in transitional societies, with a special focus on countries of the former Soviet Union (Central Asia and the Russian Federation); (3) the role of non-governmental organizations in globalization and the formation of trans-border civil society; and (4) modernity, social institutions, civil society, and health in the Middle East and Central Asia. In addition to being an active clinician, his methodological expertise is in ethnography, participant-observation, and qualitative interview techniques. Dr. Keshavjee has led efforts in Tomsk, Siberia, which is the first systematic effort to treat MDR-TB in the Russian Federation in accordance with international clinical practice standards. Between 2006 and 2008 he led the effort to treat MDR-TB/HIV co-infection in Lesotho, which was the first of its kind in this Sub-Saharan African country.
Dr. Keshavjee is an associate professor in the Department of Global Health and Social Medicine and Department of Medicine at Harvard Medical School, and Director of Harvard Medical School’s Center for Global Health Delivery–Dubai. He also serves as a physician in the Division of Global Health Equity at the Brigham and Women’s Hospital. He conducted doctoral research in medical anthropology at Harvard University on the health transition in post-Soviet Tajikistan. He has worked with the Division of Global Health Equity and the Boston-based non-profit, Partners In Health, on the implementation of a multidrug-resistant tuberculosis (MDR-TB) treatment program in Tomsk, Russia. Between 2006 and 2008, Dr. Keshavjee set up the first community-based treatment program to treat patients co-infected with HIV and MDR-TB in Lesotho. Between 2007 and 2010, Dr. Keshavjee served as the chair of the Green Light Committee Initiative, a Stop TB Partnership/WHO initiative which helped countries gain access to high-quality second-line anti-TB drugs so they can provide treatment for people with MDR-TB. He is a co-founder of Advance Access & Delivery, a non-profit committed to addressing critical challenges in access to medicines and the delivery of comprehensive healthcare, particularly for economically and socially marginalized groups.
Dr. Keshavjee’s anthropological work focuses on the anthropology of policy and healthcare delivery. He is the author of Blind Spot: How Neoliberalism Infiltrated Global Health (2014).
Dr. Keshavjee received his ScM from the Harvard School of Public Health in 1993, his PhD in Anthropology and Middle Eastern Studies from Harvard University in 1998, and his MD from Stanford University in 2001. He completed his clinician-scientist residency in Internal Medicine and a fellowship in Social Medicine at Brigham and Women’s Hospital in 2005. In addition to his appointment with the Department of Global Health and Social Medicine, Dr. Keshavjee serves on the faculty of the Division of Global Health Equity (DGHE) at Brigham and Women’s Hospital (BWH). He is also an attending physician in the Department of Medicine at BWH. He is an affiliate and Steering Committee member at the Harvard Center for Middle Eastern Studies, and affiliate and Executive Committee member at Harvard’s Davis Center for Russian and Eurasian Studies.
IUATLD European Region Meeting, Moscow, Russia, June 26, 2004
Medical education, March 1, 2004
Castro A, Merrill S, editors. Unhealthy health policy: a critical anthropological examination, January 1, 2004
Social science & medicine (1982), October 1, 2001
MS-JAMA online Link: http://www.ama-assn.org/sci-pubs/msjama/articles/vol_285/no_9/keshavjee.ht, March 7, 2001
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, March 1, 2001
JAMA, March 1, 2000
Medicines and transitions: the political economy of health and social change in post-Soviet Badakhshan, Tajikistan, September 1, 1998
JAMA, October 2, 1996
Department of Medicine, Brigham and Women’s Hospital
Partners In Health